Aimed at people who aren’t familiar with our annual Ending Age-Related Diseases conference, this video showcases this year’s speakers, getting their thoughts and perspectives on where we are now and what can be done about aging in the future.
Stay in the know
Join our newsletter to enjoy the latest aging research news, special offers for our online and physical events, and more!
Recently on Lifespan.io, we reported the rather overhyped findings of a study that presented hyperbaric oxygen therapy as an effective way to reverse human aging. The Sheekey Science Show offers its own explanation on this study and the reactions of multiple media publications to it.
A human study on the popular supplement resveratrol on heart failure patients has been published, and the results are significant. What is resveratrol? Resveratrol, is a naturally occurring stilbenoid, a type of […]
The Oxford Society for Ageing and Longevity has recently started hosting online webinars with some of the leading figures in the field. On November 25th, Dr. Aubrey de Grey from SENS Research Foundation gave […]
A new study published in the Journals of Gerontology has shown that the epigenetic clock GrimAge is a strong predictor of the effects of aging, particularly all-cause mortality: the likelihood of dying […]
Elevian is a company that we have been keeping an eye on for a while, as it works on identifying blood factors that can spur regeneration. In particular, the company has been working with a naturally occurring molecule known as […]
Recent research published in Nature Biomedical Engineering has shown a way to dramatically improve the feasibility of transplanting therapeutic cells, particularly pancreatic islet cells, while protecting them from the recipient’s immune response. […]
For this week's Lifespan News, Brent Nally discusses the 2020 Century Summit, the effects of aged blood on gene expression, lung organoids and COVID-19, OneSkin's senotherapeutic skin cream, a new book on AI and longevity, and cell virtualization for fighting cancer.